In vitro gene transfer using human papillomavirus-like particles.
about
Virus-like particles production in green plantsInteraction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodiesGene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidationPapillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses.Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.Improvement of different vaccine delivery systems for cancer therapy.Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.Cell surface-binding motifs of L2 that facilitate papillomavirus infection.DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunityDevelopment of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.Preventative and therapeutic vaccines for cervical cancer.Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope.A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirionsA Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome PackagingProduction of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells.Optimization and delivery of plasmid DNA for vaccination.Efficient intracellular assembly of papillomaviral vectorsModern uses of electron microscopy for detection of viruses.Biological gene delivery vehicles: beyond viral vectors.Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.Developments in virus-like particle-based vaccines for HIV.VLPs and particle strategies for cancer vaccines.Physical interaction of human papillomavirus virus-like particles with immune cells.Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis.DNA-induced structural changes in the papillomavirus capsid.Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cellsThe minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.
P2860
Q24650772-F86E7F4F-0974-471E-B3B0-754336EC773FQ30764287-66DCBDD0-562F-47FB-A15D-D4DCB489CFD2Q33652425-E8CE32BC-96E3-41E0-8F22-E0BC6E41C853Q33780651-934945C7-9420-418B-B973-1A82D4509C2FQ33787204-D8B26FB7-737C-4621-939A-59B3DAACD980Q33839721-A0A755C3-AEAB-46B8-8F84-D7491AA0DFB8Q33847557-8FCBE1B4-E586-4BB4-8BD0-D59EB3D0A7BDQ33848323-463D9498-2C84-46EA-9211-F919E8B020DAQ33950282-09F68E41-BFE4-4B5D-9D85-E2D4A01B4145Q34075698-CC46B83A-470A-4B1A-8D97-1314C51D035AQ34506877-D51E6AFE-E690-4A8F-ADF3-8518D91D8F05Q34617331-BBD1BA19-E0FA-4E66-B06D-A9C29DD758FAQ34743921-CA3638ED-42EF-4BFC-BA7C-7378B1103983Q35184078-BEA04BF2-4D98-403B-ADAF-4743969F1184Q35552591-24591BA0-FE12-447B-8A43-143166117EF4Q35623323-B9CB0A93-FBAC-4293-8386-702348AAB8E0Q35687869-43A888A8-5F62-41DE-8B40-9AE3401DAFBAQ35887709-F5F100CC-4047-4465-A3BF-B11010FE096DQ36422554-727D11DF-EA6C-4895-8D9A-1383BC1F28C1Q36434185-5CFABB85-50F6-4F12-9D17-CA5CB47B8980Q36555514-95923DCF-F2D8-464F-B77B-D665A4137414Q36690285-04F887B4-8AFB-4E13-8480-F040470A7227Q36944399-28A17929-E96F-4FA3-88EE-57D154D3731BQ37409983-02B89C7A-3FD1-42D0-9D21-C7183C74CA8AQ37412239-2F6F3FDD-2DAF-4E4C-BF72-10075A5F0F55Q37511451-1B21FCB0-8453-4339-AAA7-39F8A4F53878Q37834097-022DEF08-F751-4829-A3C3-B76BD5229CA2Q37951525-29F9E83E-BAB5-4B83-8DFA-B5AF2025AD79Q38059499-7E075ACF-D2BD-4D10-9B2B-687485164C6BQ38081965-4CC25FE2-91B6-4217-958B-913B779FB2CCQ38152475-DC6CE5A5-BD39-4875-BB21-86245F9CA504Q38301730-140779C2-1BE5-4F70-AA16-384EBB3455C8Q38618258-7D6A057E-96D5-474B-A369-C2563F95092FQ39041312-288D114D-F071-45D1-905E-89175A525285Q39229099-453382B3-FFFD-4932-8910-6422D0CC12A7Q39351405-0365B900-25BE-4CDA-AEFD-1AEFC54A1B17Q39606580-38B70E2A-2547-46E5-8192-1BD4AE09269AQ39683911-E6F4BABC-A1C7-484D-B19E-8D4AF21B8E50Q39732506-98A5BFD9-9AEC-4F40-A23C-70C41E45DCDCQ40446848-CFA0A889-D2D2-4776-9576-29E8D503DA39
P2860
In vitro gene transfer using human papillomavirus-like particles.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
In vitro gene transfer using human papillomavirus-like particles.
@en
In vitro gene transfer using human papillomavirus-like particles.
@nl
type
label
In vitro gene transfer using human papillomavirus-like particles.
@en
In vitro gene transfer using human papillomavirus-like particles.
@nl
prefLabel
In vitro gene transfer using human papillomavirus-like particles.
@en
In vitro gene transfer using human papillomavirus-like particles.
@nl
P2860
P356
P1476
In vitro gene transfer using human papillomavirus-like particles.
@en
P2093
P2860
P304
P356
10.1093/NAR/26.5.1317
P407
P577
1998-03-01T00:00:00Z